Home › Funds › NEXTBio Capital Management LP › IVA

NEXTBio Capital Management LP position in IVA

INVENTIVA SA · Health Care

NEXTBio Capital Management LP reported holding 1,787,984 shares of IVA (INVENTIVA SA) in its Q3 2026 13F filing — a position valued at US$6.6M, representing 2.87% of its reported portfolio and ranking #14 among its reported holdings. NEXTBio Capital Management LP has disclosed IVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.79M sh
Reported value held$6.60M
Portfolio Weight2.87%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXTBio Capital Management LP's IVA position evolved

NEXTBio Capital Management LP first disclosed a stake in IVA in Q4 2025 at 1,298,701 shares (US$6.0M). The position peaked in Q1 2026 at 1,333,484 shares, worth US$7.4M. Across 4 filings, NEXTBio Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,787,984 shares valued at US$6.6M. Notable position changes include a 34% increase in Q2 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.30M $6.04M New
Q1 2026 1.33M $7.40M Add
Q2 2026 1.79M $6.76M Add
Q3 2026 1.79M $6.60M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IVA and 13F data

IVA (INVENTIVA SA) is a Health Care company. 88 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Paradigm Biocapital Advisors LP (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IVA

All IVA fund holders →

FAQ

How long has NEXTBio Capital Management LP held IVA?

NEXTBio Capital Management LP has disclosed IVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is NEXTBio Capital Management LP's current position in IVA?

As of Q3 2026, NEXTBio Capital Management LP holds 1.79M shares of IVA (INVENTIVA SA), valued at $6.60M, representing 2.87% of its reported portfolio and ranking #14.

Has NEXTBio Capital Management LP been buying or selling IVA?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP held unchanged its position in IVA. The position peaked in Q1 2026 at 1.33M shares.

Which other funds hold IVA?

Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Paradigm Biocapital Advisors LP, among 88 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.